These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 22640224)

  • 1. Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.
    Valenta R; Campana R; Marth K; van Hage M
    J Intern Med; 2012 Aug; 272(2):144-57. PubMed ID: 22640224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant allergy vaccines based on allergen-derived B cell epitopes.
    Valenta R; Campana R; Niederberger V
    Immunol Lett; 2017 Sep; 189():19-26. PubMed ID: 28472641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives.
    Linhart B; Valenta R
    Vaccine; 2012 Jun; 30(29):4328-35. PubMed ID: 22100888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future.
    Valenta R; Campana R; Focke-Tejkl M; Niederberger V
    J Allergy Clin Immunol; 2016 Feb; 137(2):351-7. PubMed ID: 26853127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen-specific immunotherapy: towards combination vaccines for allergic and infectious diseases.
    Edlmayr J; Niespodziana K; Focke-Tejkl M; Linhart B; Valenta R
    Curr Top Microbiol Immunol; 2011; 352():121-40. PubMed ID: 21626347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
    Tulaeva I; Kratzer B; Campana R; Curin M; van Hage M; Karsonova A; Riabova K; Karaulov A; Khaitov M; Pickl WF; Valenta R
    Front Immunol; 2020; 11():1368. PubMed ID: 32733455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen immunotherapy for the treatment of respiratory allergies in the elderly.
    Hur GY; Lee JH; Park HS
    Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):304-308. PubMed ID: 28525399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategies for allergen immunotherapy.
    Carnés J; Robinson DS
    Recent Pat Inflamm Allergy Drug Discov; 2008 Jun; 2(2):92-101. PubMed ID: 19075996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficiency of peptide immunotherapy for respiratory allergy.
    Incorvaia C; Montagni M; Ridolo E
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):831-7. PubMed ID: 26901667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen immunotherapy.
    Huggins JL; Looney RJ
    Am Fam Physician; 2004 Aug; 70(4):689-96. PubMed ID: 15338781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current immunological approaches for management of allergic rhinitis and bronchial asthma.
    Srivastava D; Arora N; Singh BP
    Inflamm Res; 2009 Sep; 58(9):523-36. PubMed ID: 19333724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in immunotherapy for allergic diseases.
    El-Qutob D; Mencia G; Fernandez-Caldas E
    Recent Pat Inflamm Allergy Drug Discov; 2014 Jan; 8(1):24-35. PubMed ID: 24237114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel vaccines for allergen-specific immunotherapy.
    Akinfenwa O; Rodríguez-Domínguez A; Vrtala S; Valenta R; Campana R
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):86-99. PubMed ID: 33369572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Aspects of Allergens and Allergy.
    Valenta R; Karaulov A; Niederberger V; Gattinger P; van Hage M; Flicker S; Linhart B; Campana R; Focke-Tejkl M; Curin M; Eckl-Dorna J; Lupinek C; Resch-Marat Y; Vrtala S; Mittermann I; Garib V; Khaitov M; Valent P; Pickl WF
    Adv Immunol; 2018; 138():195-256. PubMed ID: 29731005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future of allergen-specific immunotherapy.
    Akdis CA
    Expert Opin Emerg Drugs; 2005 Feb; 10(1):1-4. PubMed ID: 15757399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant allergens: the present and the future.
    Jutel M; Solarewicz-Madejek K; Smolinska S
    Hum Vaccin Immunother; 2012 Oct; 8(10):1534-43. PubMed ID: 23095874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.